Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO2/FiO2 in severe COVID-19 pneumonia.
Chen CH, Chang KC, Lin YN, Ho MW, Cheng MY, Shih WH, Chou CH, Lin PC, Chi CY, Lu MC, Tien N, Wu MY, Chang SS, Hsu WH, Shyu WC, Cho DY, Jeng LB.
Chen CH, et al. Among authors: shih wh.
Front Med (Lausanne). 2022 Sep 23;9:1001979. doi: 10.3389/fmed.2022.1001979. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36213639
Free PMC article.